Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D03NYF
|
|||
| Former ID |
DNC005002
|
|||
| Drug Name |
4-Biphenyl-4-ylethynyl-2-methyl-thiazole
|
|||
| Synonyms |
CHEMBL185078; 4-Biphenyl-4-ylethynyl-2-methyl-thiazole
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C18H13NS
|
|||
| Canonical SMILES |
CC1=NC(=CS1)C#CC2=CC=C(C=C2)C3=CC=CC=C3
|
|||
| InChI |
1S/C18H13NS/c1-14-19-18(13-20-14)12-9-15-7-10-17(11-8-15)16-5-3-2-4-6-16/h2-8,10-11,13H,1H3
|
|||
| InChIKey |
DGRLZFWNJWSHOX-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | 5-[(2-Methyl-1,3-thiazol-4-yl)ethynyl]-2,3'-bipyridine: a highly potent, orally active metabotropic glutamate subtype 5 (mGlu5) receptor antagonist... Bioorg Med Chem Lett. 2004 Aug 2;14(15):3993-6. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.